Literature DB >> 3314323

Human cochlear pathology in aminoglycoside ototoxicity--a review.

E H Huizing1, J C de Groot.   

Abstract

The pathological findings due to aminoglycoside ototoxicity in man, as reported in the literature, is reviewed. 21 cases (40 ears) have been studied after serial sectioning, 8 cases (12 ears) have been investigated by the microdissection and surface preparation technique. The combination of both methods provides maximal information. OHCs are primarily affected, followed by IHC loss. Degeneration starts at the basal coil and proceeds towards the apex. The stria vascularis becomes involved in all turns. It is not clear whether stria degeneration is primary or secondary. Supporting cells, nerve fibres and ganglion cells degenerate secondary to hair cell loss. In some cases ingrowth of myelinated nerve fibres in areas with complete destruction of the organ of Corti has been observed. Ototoxic lesions can be asymmetric. Attention is drawn to the audiometric Z-curve in moderate lesions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3314323     DOI: 10.3109/00016488709124984

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  17 in total

1.  Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype.

Authors:  M C Liberman; E Tartaglini; J C Fleming; E J Neufeld
Journal:  J Assoc Res Otolaryngol       Date:  2006-04-27

Review 2.  Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.

Authors:  K Mörike; M Schwab; U Klotz
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

Review 3.  New developments in aminoglycoside therapy and ototoxicity.

Authors:  Jing Xie; Andra E Talaska; Jochen Schacht
Journal:  Hear Res       Date:  2011-05-27       Impact factor: 3.208

4.  Corticotropin-releasing factor-2 activation prevents gentamicin-induced oxidative stress in cells derived from the inner ear.

Authors:  Johnvesly Basappa; Sevin Turcan; Douglas E Vetter
Journal:  J Neurosci Res       Date:  2010-10       Impact factor: 4.164

Review 5.  Cochlear implantation in common forms of genetic deafness.

Authors:  Richard J Vivero; Kenneth Fan; Simon Angeli; Thomas J Balkany; Xue Z Liu
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2010-07-22       Impact factor: 1.675

6.  Clinical Considerations for Routine Auditory and Vestibular Monitoring in Patients With Cystic Fibrosis.

Authors:  Angela C Garinis; Gayla L Poling; Ronald C Rubenstein; Dawn Konrad-Martin; Timothy E Hullar; David M Baguley; Holly L Burrows; Jennifer A Chisholm; Amy Custer; Laura Dreisbach Hawe; Lisa L Hunter; Theodore K Marras; Candice E Ortiz; Lucretia Petersen; Peter S Steyger; Kevin Winthrop; Erika M Zettner; Khaya Clark; Michelle Hungerford; Jay J Vachhani; Carmen C Brewer
Journal:  Am J Audiol       Date:  2021-09-22       Impact factor: 1.636

Review 7.  Experimental, clinical and preventive aspects of ototoxicity.

Authors:  A A Chiodo; P W Alberti
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

8.  Pathological findings in the human auditory system following long-standing gentamicin ototoxicity.

Authors:  R M Backus; J C De Groot; R A Tange; E H Huizing
Journal:  Arch Otorhinolaryngol       Date:  1987

9.  Shifts in auditory brainstem response latencies following plasma-level-controlled aminoglycoside therapy.

Authors:  M A Hotz; J H Allum; G Kaufmann; F Follath; C R Pfaltz
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

10.  New criteria of indication and selection of patients to cochlear implant.

Authors:  André L L Sampaio; Mercêdes F S Araújo; Carlos A C P Oliveira
Journal:  Int J Otolaryngol       Date:  2011-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.